Skip to content
value.today

Atreca, Inc.

🇺🇸 San Carlos, California, USABiotechnologyFounded 2010
Total raised
$220 M
4 rounds on record
Latest round
$125 M
Sep 2018
First round on record
Jun 2012
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Atreca, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2018$125 MNo. 4$50 to $250 million

Atreca, Inc.: Raise no. 4, Sep 2018

Investors in this round

43 investors had bought by the notice of Sep 19, 2018: 43 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 8 investors are named for Atreca, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$125 M of $125 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$4,500,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • John Orwin · Executive Officer, Director
  • Susan Berland · Executive Officer
  • Tito Serafini · Executive Officer, Director
  • Brian Atwood · Director
  • David Lacey · Director
  • Franklin Berger · Director
  • Lawrence Steinman · Director
  • William Robinson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Cowen and Company, LLC (CRD 7616) · New York, New YorkSold in CA, MA, NY

Signed by Susan Berland, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 19, 2018. Read the notice at the SEC.

equitySEC
Aug 2017$35 MNo. 3$10 to $50 million

Atreca, Inc.: Raise no. 3, Aug 2017

Investors in this round

71 investors had bought by the notice of Dec 7, 2017: 71 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 8 investors are named for Atreca, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$35 M of $35 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$390,338
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Susan Berland · Executive Officer
  • Tito Serafini · Executive Officer, Director
  • Brian Atwood · Director
  • David Lacey · Director
  • Franklin Berger · Director
  • Lawrence Steinman · Director
  • William Robinson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • CIM SECURITIES, LLC (CRD 120852) · Centennial, ColoradoSold in AL, CA, CO, CT, DE, FL, GA, HI, IL, MA, MD, NC, NJ, NY, SC, TX, WA, WY, and outside the US

Signed by Susan Berland, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Dec 7, 2017. Read the notice at the SEC.

equitySEC
Aug 2015$57 MNo. 2$50 to $250 million

Atreca, Inc.: Raise no. 2, Aug 2015

Investors in this round

88 investors had bought by the notice of Dec 4, 2015: 88 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 8 investors are named for Atreca, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$57 M of $57 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$2,741,872
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Tito Serafini · Executive Officer, Director
  • Brian Atwood · Director
  • Franklin Berger · Director
  • Lawrence Steinman · Director
  • William Robinson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Brookline Group, LLC (CRD 153587) · Birmingham, AlabamaSold in AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MS, MT, NC, NE, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, VT, WA, WI, WV, WY, and outside the US

Remarks in the notice

  • On fees: “Includes the issuance of a warrant to purchase Series A Preferred Stock underlying shares of Common Stock representing a value of $723,000.”

Signed by Danielle Naftulin, Assistant Secretary. Source: SEC Form D, newest notice filed Dec 4, 2015. Read the notice at the SEC.

equity, optionsSEC
Jun 2012$3 MNo. 1$2 to $10 million

Atreca, Inc.: Raise no. 1, Jun 2012

Investors in this round

1 investor had bought by the notice of Sep 26, 2012: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 8 investors are named for Atreca, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$3 M of $6 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt, other: "Offering of convertible promissory notes (""Notes""), the underlying shares of Preferred Stock issuable upon conversion of the Notes and the underlying shares of Common Stock issuable upon conversion
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Tito Serafini · Executive Officer, Director
  • Lawrence Steinman · Director
  • William Robinson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Danielle Naftulin, Assistant Secretary. Source: SEC Form D, newest notice filed Sep 26, 2012. Read the notice at the SEC.

equity, debtSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Atreca, Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2018).

    SEC Form D · Sep 2018

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Sep 2018

That is all the official record says: Atreca, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

8 named in official filings. Open an investor to see everything it has backed.

Investors in Atreca, Inc.
InvestorKindAmountRoundRoleSource
Baker Bros. Advisors (GP) LLCFund or asset managernot statednot statedHeld Series A, B and C2 preferred stock, 10% owner (Form 3, 2019)SEC Form 3
Baker Bros. Advisors LPFund or asset managernot statednot statedHeld Series A, B and C2 preferred stock, 10% owner (Form 3, 2019)SEC Form 3
Bill & Melinda Gates FoundationOthernot statednot statedHeld Series A preferred stock, 10% owner (Form 3, 2019)SEC Form 3
Franklin M. BergerPersonnot statednot statedHeld Series A, B and C1 preferred stock, director (Form 3, 2019)SEC Form 3
Hadley Harbor Master Investors (Cayman) II L.P.Fund or asset managernot statednot statedHeld Series B and C1 preferred stock, 10% owner (Form 3, 2019)SEC Form 3
Lawrence SteinmanPersonnot statednot statedHeld Series A preferred stock, director (Form 3, 2019)SEC Form 3
Redmile Group, LLCFund or asset managernot statednot statedHeld Series C1 preferred stock, 10% owner (Form 3, 2019)SEC Form 3
William Hewitt RobinsonPersonnot statednot statedHeld Series A and B preferred stock, director (Form 3, 2019)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 88 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Atreca, Inc.
NameRoleNamed in
John OrwinExecutive officerSep 2018
Susan BerlandExecutive officerSep 2018
Tito SerafiniExecutive officerSep 2018
Brian AtwoodDirectorSep 2018
David LaceyDirectorSep 2018
Franklin BergerDirectorSep 2018
John OrwinDirectorSep 2018
Lawrence SteinmanDirectorSep 2018
Tito SerafiniDirectorSep 2018
William RobinsonDirectorSep 2018